{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:44:04Z","timestamp":1792039444296,"version":"4.4.0"},"reference-count":52,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.3892\/ijmm.2017.2903","type":"journal-article","created":{"date-parts":[[2017,2,21]],"date-time":"2017-02-21T12:22:02Z","timestamp":1487679722000},"page":"861-868","source":"Crossref","is-referenced-by-count":12,"title":["Overexpression of wild-type p21Ras plays a prominent role in colorectal cancer"],"prefix":"10.3892","volume":"39","author":[{"given":"Shuang","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Yan","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Bin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Liang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Ling","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Ling","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Lun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2017,2,21]]},"reference":[{"key":"key20180107234802_b1-ijmm-39-04-0861","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"key20180107234802_b2-ijmm-39-04-0861","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S0140-6736(10)60353-4","article-title":"Colorectal cancer","volume":"375","author":"Cunningham","year":"2010","journal-title":"Lancet"},{"key":"key20180107234802_b3-ijmm-39-04-0861","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1056\/NEJMoa071834","article-title":"Cetuximab for the treatment of colorectal cancer","volume":"357","author":"Jonker","year":"2007","journal-title":"N Engl J Med"},{"key":"key20180107234802_b4-ijmm-39-04-0861","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1200\/JCO.2007.11.5956","article-title":"Epidermal growth factor receptor gene copy number and clinical outcome of metastatic colorectal cancer treated with panitumumab","volume":"25","author":"Sartore-Bianchi","year":"2007","journal-title":"J Clin Oncol"},{"key":"key20180107234802_b5-ijmm-39-04-0861","doi-asserted-by":"crossref","first-page":"7944","DOI":"10.3748\/wjg.v21.i26.7944","article-title":"Familial colorectal cancer screening: When and what to do?","volume":"21","author":"Del Vecchio Blanco","year":"2015","journal-title":"World J Gastroenterol"},{"key":"key20180107234802_b6-ijmm-39-04-0861","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/bjc.2013.753","article-title":"Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer","volume":"110","author":"Jonker","year":"2014","journal-title":"Br J Cancer"},{"key":"key20180107234802_b7-ijmm-39-04-0861","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1093\/jnci\/93.14.1062","article-title":"Blocking oncogenic Ras signaling for cancer therapy","volume":"93","author":"Adjei","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"key20180107234802_b8-ijmm-39-04-0861","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/327293a0","article-title":"Prevalence of ras gene mutations in human colorectal cancers","volume":"327","author":"Bos","year":"1987","journal-title":"Nature"},{"key":"key20180107234802_b9-ijmm-39-04-0861","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/bjc.1997.56","article-title":"A detailed analysis of the role of K-ras gene mutation in the progression of colorectal adenoma","volume":"75","author":"Ohnishi","year":"1997","journal-title":"Br J Cancer"},{"key":"key20180107234802_b10-ijmm-39-04-0861","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.2217\/PGS.15.63","article-title":"Molecular biomarkers in colorectal carcinoma","volume":"16","author":"Puerta-Garc\u00eda","year":"2015","journal-title":"Pharmacogenomics"},{"key":"key20180107234802_b11-ijmm-39-04-0861","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1309\/AJCP7FO2VAXIVSTP","article-title":"KRAS gene mutation in colorectal cancer is correlated with increased proliferation and spontaneous apoptosis","volume":"135","author":"Liu","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"key20180107234802_b12-ijmm-39-04-0861","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1054\/bjoc.2001.1964","article-title":"Kirsten ras mutations in patients with colorectal cancer: The 'RASCAL II' study","volume":"85","author":"Andreyev","year":"2001","journal-title":"Br J Cancer"},{"key":"key20180107234802_b13-ijmm-39-04-0861","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1159\/000356814","article-title":"RAS, BRAF, and TP53 gene mutations in Taiwanese colorectal cancer patients","volume":"36","author":"Chang","year":"2013","journal-title":"Onkologie"},{"key":"key20180107234802_b14-ijmm-39-04-0861","doi-asserted-by":"crossref","first-page":"729","DOI":"10.5603\/FHC.2011.0097","article-title":"Concurrent mutation in exons 1 and 2 of the K-ras oncogene in colorectal cancer","volume":"49","author":"Palmirotta","year":"2011","journal-title":"Folia Histochem Cytobiol"},{"key":"key20180107234802_b15-ijmm-39-04-0861","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/BF02555769","article-title":"Detection of ras gene alterations and ras proteins in colorectal cancer","volume":"32","author":"Salhab","year":"1989","journal-title":"Dis Colon Rectum"},{"key":"key20180107234802_b16-ijmm-39-04-0861","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1445-2197.1997.tb01954.x","article-title":"Frequency and clinico-pathological associations of ras mutations in colorectal cancer in the Victorian population","volume":"67","author":"Thomas","year":"1997","journal-title":"Aust NZ J Surg"},{"key":"key20180107234802_b17-ijmm-39-04-0861","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/cncr.29196","article-title":"RAS mutations affect pattern of metastatic spread and increase propensity for brain metastasis in colorectal cancer","volume":"121","author":"Yaeger","year":"2015","journal-title":"Cancer"},{"key":"key20180107234802_b18-ijmm-39-04-0861","first-page":"413","article-title":"Mutations of ras genes in human tumors (Review)","volume":"7","author":"Kiaris","year":"1995","journal-title":"Int J Oncol"},{"key":"key20180107234802_b19-ijmm-39-04-0861","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/PDM.0b013e3181c93fd1","article-title":"NRAS mutations are rare in colorectal cancer","volume":"19","author":"Irahara","year":"2010","journal-title":"Diagn Mol Pathol"},{"key":"key20180107234802_b20-ijmm-39-04-0861","first-page":"1451","article-title":"Activation of the ras genes in malignant and premalignant colorectal tumors","volume":"5","author":"Glarakis","year":"1998","journal-title":"Oncol Rep"},{"key":"key20180107234802_b21-ijmm-39-04-0861","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s00384-015-2448-7","article-title":"HRAS G13D, a new mutation implicated in the resistance to anti-EGFR therapies in colorectal cancer, a case report","volume":"31","author":"Boidot","year":"2016","journal-title":"Int J Colorectal Dis"},{"key":"key20180107234802_b22-ijmm-39-04-0861","first-page":"237","article-title":"Normal ras genes: Their onco-suppressor and pro-apoptotic functions (Review)","volume":"21","author":"Spandidos","year":"2002","journal-title":"Int J Oncol"},{"key":"key20180107234802_b23-ijmm-39-04-0861","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.18632\/oncotarget.6461","article-title":"Overexpression of wild-type EGFR is tumorigenic and denotes a therapeutic target in non-small cell lung cancer","volume":"7","author":"Xu","year":"2016","journal-title":"Oncotarget"},{"key":"key20180107234802_b24-ijmm-39-04-0861","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1002\/hep.24208","article-title":"Notch1 differentially regulates oncogenesis by wild-type p53 overexpression and P53 mutation in grade III hepatocellular carcinoma","volume":"53","author":"Lim","year":"2011","journal-title":"Hepatology"},{"issue":"Suppl 4","key":"key20180107234802_b25-ijmm-39-04-0861","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/annonc\/mdf665","article-title":"Molecular and biochemical markers in colorectal cancer","volume":"13","author":"McDermott","year":"2002","journal-title":"Ann Oncol"},{"key":"key20180107234802_b26-ijmm-39-04-0861","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12885-016-2168-6","article-title":"A novel anti-p21R as scFv antibody reacting specifically with human tumour cell lines and primary tumour tissues","volume":"16","author":"Yang","year":"2016","journal-title":"BMC Cancer"},{"key":"key20180107234802_b27-ijmm-39-04-0861","first-page":"5419","article-title":"Immunohistochemical analyses of estrogen receptor in endometrial adenocarcinoma using a monoclonal antibody","volume":"46","author":"Budwit-Novotny","year":"1986","journal-title":"Cancer Res"},{"key":"key20180107234802_b28-ijmm-39-04-0861","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/GCO.0b013e328012980a","article-title":"HER2\/neu role in breast cancer: From a prognostic foe to a predictive friend","volume":"19","author":"Ferretti","year":"2007","journal-title":"Curr Opin Obstet Gynecol"},{"key":"key20180107234802_b29-ijmm-39-04-0861","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/annonc\/mdt543","article-title":"Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer","volume":"25","author":"Baselga","year":"2014","journal-title":"Ann Oncol"},{"key":"key20180107234802_b30-ijmm-39-04-0861","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1470-2045(13)70130-X","article-title":"Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): Overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study","volume":"14","author":"Swain","year":"2013","journal-title":"Lancet Oncol"},{"key":"key20180107234802_b31-ijmm-39-04-0861","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1200\/JCO.2011.40.5241","article-title":"Randomized trial of lapatinib versus placebo added to paclitaxel in the treatment of human epidermal growth factor receptor 2-overexpressing metastatic breast cancer","volume":"31","author":"Guan","year":"2013","journal-title":"J Clin Oncol"},{"key":"key20180107234802_b32-ijmm-39-04-0861","first-page":"16140","article-title":"Cetuximab combined with chemotherapy is beneficial for patients with advanced non-small cell lung cancer after EGFR-tyrosine kinase inhibitors failure","volume":"8","author":"Zhang","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"key20180107234802_b33-ijmm-39-04-0861","doi-asserted-by":"crossref","first-page":"s4597","DOI":"10.1158\/1078-0432.CCR-07-0335","article-title":"Antibodies to the epidermal growth factor receptor in non small cell lung cancer: current status of matuzumab and panitumumab","volume":"13","author":"Socinski","year":"2007","journal-title":"Clin Cancer Res"},{"key":"key20180107234802_b34-ijmm-39-04-0861","first-page":"289","article-title":"The emerging role of nimotuzumab in the treatment of non-small cell lung cancer","volume":"4","author":"Boland","year":"2010","journal-title":"Biologics"},{"key":"key20180107234802_b35-ijmm-39-04-0861","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.1073\/pnas.81.16.5227","article-title":"Monoclonal antibodies of predefined specificity detect activated ras gene expression in human mammary and colon carcinomas","volume":"81","author":"Hand","year":"1984","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107234802_b36-ijmm-39-04-0861","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1084\/jem.161.5.1213","article-title":"ras oncogene P21 expression is increased in premalignant lesions and high grade bladder carcinoma","volume":"161","author":"Viola","year":"1985","journal-title":"J Exp Med"},{"key":"key20180107234802_b37-ijmm-39-04-0861","first-page":"2511","article-title":"Expression of the 21,000 molecular weight ras protein in a spectrum of benign and malignant human mammary tissues","volume":"46","author":"Ohuchi","year":"1986","journal-title":"Cancer Res"},{"key":"key20180107234802_b38-ijmm-39-04-0861","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1136\/jcp.39.4.428","article-title":"Immunohistochemical detection of ras oncogene P21 product in benign and malignant mammary tissue in man","volume":"39","author":"Ghosh","year":"1986","journal-title":"J Clin Pathol"},{"key":"key20180107234802_b39-ijmm-39-04-0861","first-page":"1413","article-title":"Enhanced expression of c-Ha-ras p21 in human stomach adenocarcinomas defined by immunoassays using monoclonal antibodies and in situ hybridization","volume":"47","author":"Ohuchi","year":"1987","journal-title":"Cancer Res"},{"key":"key20180107234802_b40-ijmm-39-04-0861","first-page":"60","article-title":"Expression of ras oncogene P21 antigen in normal and proliferative thyroid tissues","volume":"127","author":"Johnson","year":"1987","journal-title":"Am J Pathol"},{"key":"key20180107234802_b41-ijmm-39-04-0861","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/bjc.1994.195","article-title":"Expression of ras oncogene P21 protein in normal and neoplastic laryngeal tissues: Correlation with histopathological features and epidermal growth factor receptors","volume":"69","author":"Scambia","year":"1994","journal-title":"Br J Cancer"},{"key":"key20180107234802_b42-ijmm-39-04-0861","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.3892\/ijo.2016.3334","article-title":"The antitumor efficacy of a novel adenovirus-mediated anti-p21Ras single chain fragment variable antibody on human cancers in vitro and in vivo","volume":"48","author":"Yang","year":"2016","journal-title":"Int J Oncol"},{"key":"key20180107234802_b43-ijmm-39-04-0861","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/PAI.0b013e3182240de1","article-title":"Relationship between expression of ras P21 oncoprotein and mutation status of the K-ras gene in sporadic colorectal cancer patients in Tunisia","volume":"20","author":"Sammoud","year":"2012","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"key20180107234802_b44-ijmm-39-04-0861","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/jcp.40.2.157","article-title":"Immunohistochemical staining of colorectal tissues with monoclonal antibodies to ras oncogene p21 product and carbohydrate determinant antigen 19-9","volume":"40","author":"Allen","year":"1987","journal-title":"J Clin Pathol"},{"key":"key20180107234802_b45-ijmm-39-04-0861","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/0277-5379(91)90437-I","article-title":"ras P21 expression in relation to DNA ploidy, S-phase fraction and prognosis in colorectal adenocarcinoma","volume":"27","author":"Sun","year":"1991","journal-title":"Eur J Cancer"},{"key":"key20180107234802_b46-ijmm-39-04-0861","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1093\/annonc\/mdu252","article-title":"Clinicopathologic characteristics and gene expression analyses of non-KRAS 12\/13, RAS-mutated metastatic colorectal cancer","volume":"25","author":"Morris","year":"2014","journal-title":"Ann Oncol"},{"key":"key20180107234802_b47-ijmm-39-04-0861","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jnci.2013.01.003","article-title":"Immunohistochemical assay for detection of K-ras protein expression in metastatic colorectal cancer","volume":"25","author":"Elsabah","year":"2013","journal-title":"J Egypt Natl Canc Inst"},{"key":"key20180107234802_b48-ijmm-39-04-0861","first-page":"685","article-title":"K-ras and P53 mutations and overexpressions as prognostic factors in female rectal carcinoma","volume":"19","author":"Hirvikoski","year":"1999","journal-title":"Anticancer Res"},{"issue":"Suppl 1","key":"key20180107234802_b49-ijmm-39-04-0861","first-page":"52","article-title":"Clinical usefulness of K-RAS mutation detection in colorectal cancer and in surgical margins of the colon","volume":"49","author":"Okulczyk","year":"2004","journal-title":"Rocz Akad Med Bialymst"},{"key":"key20180107234802_b50-ijmm-39-04-0861","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.celrep.2015.06.044","article-title":"Wild-type N-Ras, overexpressed in basal-like breast cancer, promotes tumor formation by inducing IL-8 secretion via JAK2 activation","volume":"12","author":"Zheng","year":"2015","journal-title":"Cell Rep"},{"key":"key20180107234802_b51-ijmm-39-04-0861","first-page":"67","article-title":"The normal human H-ras1 gene can act as an onco-suppressor","volume":"9","author":"Spandidos","year":"1988","journal-title":"Br J Cancer Suppl"},{"key":"key20180107234802_b52-ijmm-39-04-0861","first-page":"1543","article-title":"Expression of the normal H-ras1 gene can suppress the transformed and tumorigenic phenotypes induced by mutant ras genes","volume":"10","author":"Spandidos","year":"1990","journal-title":"Anticancer Res"}],"container-title":["International Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijmm.2017.2903\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,24]],"date-time":"2022-07-24T13:57:54Z","timestamp":1658671074000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijmm.2017.2903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,21]]},"references-count":52,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,2,21]]},"published-print":{"date-parts":[[2017,4]]}},"alternative-id":["10.3892\/ijmm.2017.2903"],"URL":"https:\/\/doi.org\/10.3892\/ijmm.2017.2903","relation":{},"ISSN":["1107-3756","1791-244X"],"issn-type":[{"value":"1107-3756","type":"print"},{"value":"1791-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,21]]}}}